1. Home
  2. SAR vs NMRA Comparison

SAR vs NMRA Comparison

Compare SAR & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAR
  • NMRA
  • Stock Information
  • Founded
  • SAR 2007
  • NMRA 2019
  • Country
  • SAR United States
  • NMRA United States
  • Employees
  • SAR N/A
  • NMRA N/A
  • Industry
  • SAR Investment Managers
  • NMRA
  • Sector
  • SAR Finance
  • NMRA
  • Exchange
  • SAR Nasdaq
  • NMRA Nasdaq
  • Market Cap
  • SAR 309.4M
  • NMRA 287.6M
  • IPO Year
  • SAR 2007
  • NMRA 2023
  • Fundamental
  • Price
  • SAR $23.49
  • NMRA $0.65
  • Analyst Decision
  • SAR Buy
  • NMRA Buy
  • Analyst Count
  • SAR 4
  • NMRA 8
  • Target Price
  • SAR $25.08
  • NMRA $9.29
  • AVG Volume (30 Days)
  • SAR 99.2K
  • NMRA 1.2M
  • Earning Date
  • SAR 05-07-2025
  • NMRA 05-06-2025
  • Dividend Yield
  • SAR 14.15%
  • NMRA N/A
  • EPS Growth
  • SAR 33.28
  • NMRA N/A
  • EPS
  • SAR 2.49
  • NMRA N/A
  • Revenue
  • SAR $154,793,533.00
  • NMRA N/A
  • Revenue This Year
  • SAR $6.07
  • NMRA N/A
  • Revenue Next Year
  • SAR N/A
  • NMRA N/A
  • P/E Ratio
  • SAR $9.45
  • NMRA N/A
  • Revenue Growth
  • SAR 11.52
  • NMRA N/A
  • 52 Week Low
  • SAR $21.10
  • NMRA $0.62
  • 52 Week High
  • SAR $26.49
  • NMRA $17.19
  • Technical
  • Relative Strength Index (RSI)
  • SAR 47.54
  • NMRA 22.34
  • Support Level
  • SAR $22.60
  • NMRA $0.64
  • Resistance Level
  • SAR $23.24
  • NMRA $0.83
  • Average True Range (ATR)
  • SAR 0.92
  • NMRA 0.09
  • MACD
  • SAR -0.04
  • NMRA 0.02
  • Stochastic Oscillator
  • SAR 53.35
  • NMRA 6.68

About SAR Saratoga Investment Corp New

Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests primarily in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

Share on Social Networks: